
Diagnostic Radiopharmaceuticals and Contrast Media
Description
Global Diagnostic Radiopharmaceuticals and Contrast Media Market to Reach US$13.6 Billion by 2030
The global market for Diagnostic Radiopharmaceuticals and Contrast Media estimated at US$10.9 Billion in the year 2024, is expected to reach US$13.6 Billion by 2030, growing at a CAGR of 3.7% over the analysis period 2024-2030. Contrast Media, one of the segments analyzed in the report, is expected to record a 4.2% CAGR and reach US$7.5 Billion by the end of the analysis period. Growth in the Radiopharmaceuticals segment is estimated at 3.1% CAGR over the analysis period.
The U.S. Market is Estimated at US$2.9 Billion While China is Forecast to Grow at 5.7% CAGR
The Diagnostic Radiopharmaceuticals and Contrast Media market in the U.S. is estimated at US$2.9 Billion in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$2.8 Billion by the year 2030 trailing a CAGR of 5.7% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.3% and 3.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.7% CAGR.
strong>Global Diagnostic Radiopharmaceuticals and Contrast Media Market - Key Trends and Drivers Summarized
How Are Diagnostic Radiopharmaceuticals and Contrast Media Revolutionizing Medical Imaging?
Diagnostic radiopharmaceuticals and contrast media are cornerstone technologies in modern medical imaging, enhancing the clarity and detail of images obtained via modalities such as MRI, CT scans, and PET scans. Radiopharmaceuticals involve the use of radioactive compounds that are administered to the patient to target specific tissues or organs. The emitted radiation from these compounds is then captured by specialized cameras to create detailed images of the body`s internal structures and functions, offering invaluable insights into a variety of diseases, including cancer, heart disease, and neurological disorders. Contrast media, on the other hand, are substances used to improve the visibility of internal bodily structures in imaging studies. These agents, which can be iodine-based or gadolinium-based depending on the imaging technique, help to clearly delineate between different types of tissues, making it easier for physicians to diagnose abnormalities or monitor disease progression.
What Technological Advancements Are Enhancing Diagnostic Imaging?
The field of diagnostic radiopharmaceuticals and contrast media is continually evolving, driven by technological advancements that aim to increase the efficacy and safety of these agents. Innovations in radiopharmaceuticals include the development of new radioactive tracers that have improved specificity for certain types of cancer cells, allowing for earlier detection and more precise targeting in treatment planning. Similarly, advances in contrast media are focused on enhancing the safety profiles of these agents, reducing the risk of adverse reactions, and improving the overall patient experience. Additionally, new formulation and delivery techniques are being developed to enhance the biocompatibility and effectiveness of contrast agents. These include nanoparticles and other encapsulation technologies that can improve the distribution and retention of these agents in the body, providing clearer and more detailed images.
How Do Diagnostic Radiopharmaceuticals and Contrast Media Impact Patient Care?
The use of diagnostic radiopharmaceuticals and contrast media has a profound impact on patient care, significantly improving the accuracy of diagnoses and the effectiveness of subsequent treatments. By enabling early detection of diseases and providing detailed insights into physiological and pathological processes, these agents allow for timely intervention, which can be critical in treating serious conditions such as cancer and heart disease. Moreover, the detailed information obtained from enhanced imaging guides physicians in planning more effective treatment strategies, monitoring responses to treatments, and adjusting therapies as needed. This precision in medical imaging not only improves outcomes but also minimizes unnecessary procedures, thereby reducing the overall healthcare costs and enhancing patient safety.
What Drives the Growing Market for Diagnostic Radiopharmaceuticals and Contrast Media?
The growth in the diagnostic radiopharmaceuticals and contrast media market is driven by several factors, including the increasing prevalence of chronic diseases, advancements in medical imaging technologies, and a rising emphasis on personalized medicine. As populations age globally, the incidence of conditions such as cancer, cardiovascular diseases, and neurological disorders continues to rise, necessitating advanced diagnostic solutions for effective management. The continuous improvement in imaging technologies and the integration of artificial intelligence to analyze imaging data more efficiently are also significant contributors to market expansion. Furthermore, there is a growing demand for precise diagnostic tools that can tailor treatments to individual patient needs, aligning with the broader shift towards personalized healthcare. These drivers, coupled with increasing healthcare expenditure and improved healthcare infrastructure across emerging markets, ensure a dynamic and growing demand for diagnostic radiopharmaceuticals and contrast media, underscoring their essential role in modern medical practice.
SCOPE OF STUDY:The report analyzes the Diagnostic Radiopharmaceuticals and Contrast Media market in terms of units by the following Segments, and Geographic Regions/Countries:
Segments:
Segment (Contrast Media, Radiopharmaceuticals)
Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.
Select Competitors (Total 38 Featured) -
- AMAG Pharmaceuticals, Inc.
- Bayer Healthcare AG
- Bracco Imaging SpA
- Daiichi Sankyo Co., Ltd.
- GE Healthcare
- Guerbet Group
- Lantheus Holdings, Inc.
- Mallinckrodt PLC
- Medtronic PLC
- Nordion, Inc.
We`re transforming market and competitive intelligence with validated expert content and AI tools.
Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.
TARIFF IMPACT FACTOR
Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.
Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.
The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.
Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.
Table of Contents
- I. METHODOLOGY
- II. EXECUTIVE SUMMARY
- 1. MARKET OVERVIEW
- Influencer Market Insights
- Global Economic Update
- Diagnostic Radiopharmaceuticals and Contrast Media – Global Key Competitors Percentage Market Share in 2025 (E)
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
- 2. FOCUS ON SELECT PLAYERS
- 3. MARKET TRENDS & DRIVERS
- Growth in Cancer Prevalence Worldwide Spurs Demand for Enhanced Imaging Solutions
- Technological Innovations in Radiopharmaceuticals Expand Therapeutic Applications
- Increasing Use of PET and SPECT Scans Bolsters Market Growth
- Development of Targeted Radiotracers Sets the Stage for Precision Medicine
- Enhanced Focus on Patient Safety and Contrast Media Efficiency
- Environmental and Health Concerns Regarding Gadolinium-based Agents
- Growing Applications in Neurological and Cardiac Imaging Expand Market Reach
- 4. GLOBAL MARKET PERSPECTIVE
- TABLE 1: World Recent Past, Current & Future Analysis for Diagnostic Radiopharmaceuticals and Contrast Media by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 2: World Historic Review for Diagnostic Radiopharmaceuticals and Contrast Media by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 3: World 15-Year Perspective for Diagnostic Radiopharmaceuticals and Contrast Media by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
- TABLE 4: World Recent Past, Current & Future Analysis for Radiopharmaceuticals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 5: World Historic Review for Radiopharmaceuticals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 6: World 15-Year Perspective for Radiopharmaceuticals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
- TABLE 7: World Recent Past, Current & Future Analysis for Contrast Media by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 8: World Historic Review for Contrast Media by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 9: World 15-Year Perspective for Contrast Media by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
- TABLE 10: World Diagnostic Radiopharmaceuticals and Contrast Media Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
- III. MARKET ANALYSIS
- UNITED STATES
- Diagnostic Radiopharmaceuticals and Contrast Media Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
- TABLE 11: USA Recent Past, Current & Future Analysis for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Contrast Media and Radiopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 12: USA Historic Review for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Contrast Media and Radiopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 13: USA 15-Year Perspective for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Percentage Breakdown of Value Sales for Contrast Media and Radiopharmaceuticals for the Years 2015, 2025 & 2030
- CANADA
- TABLE 14: Canada Recent Past, Current & Future Analysis for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Contrast Media and Radiopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 15: Canada Historic Review for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Contrast Media and Radiopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 16: Canada 15-Year Perspective for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Percentage Breakdown of Value Sales for Contrast Media and Radiopharmaceuticals for the Years 2015, 2025 & 2030
- JAPAN
- Diagnostic Radiopharmaceuticals and Contrast Media Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
- TABLE 17: Japan Recent Past, Current & Future Analysis for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Contrast Media and Radiopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 18: Japan Historic Review for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Contrast Media and Radiopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 19: Japan 15-Year Perspective for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Percentage Breakdown of Value Sales for Contrast Media and Radiopharmaceuticals for the Years 2015, 2025 & 2030
- CHINA
- Diagnostic Radiopharmaceuticals and Contrast Media Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
- TABLE 20: China Recent Past, Current & Future Analysis for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Contrast Media and Radiopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 21: China Historic Review for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Contrast Media and Radiopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 22: China 15-Year Perspective for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Percentage Breakdown of Value Sales for Contrast Media and Radiopharmaceuticals for the Years 2015, 2025 & 2030
- EUROPE
- Diagnostic Radiopharmaceuticals and Contrast Media Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
- TABLE 23: Europe Recent Past, Current & Future Analysis for Diagnostic Radiopharmaceuticals and Contrast Media by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 24: Europe Historic Review for Diagnostic Radiopharmaceuticals and Contrast Media by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 25: Europe 15-Year Perspective for Diagnostic Radiopharmaceuticals and Contrast Media by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
- TABLE 26: Europe Recent Past, Current & Future Analysis for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Contrast Media and Radiopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 27: Europe Historic Review for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Contrast Media and Radiopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 28: Europe 15-Year Perspective for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Percentage Breakdown of Value Sales for Contrast Media and Radiopharmaceuticals for the Years 2015, 2025 & 2030
- FRANCE
- Diagnostic Radiopharmaceuticals and Contrast Media Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
- TABLE 29: France Recent Past, Current & Future Analysis for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Contrast Media and Radiopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 30: France Historic Review for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Contrast Media and Radiopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 31: France 15-Year Perspective for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Percentage Breakdown of Value Sales for Contrast Media and Radiopharmaceuticals for the Years 2015, 2025 & 2030
- GERMANY
- Diagnostic Radiopharmaceuticals and Contrast Media Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
- TABLE 32: Germany Recent Past, Current & Future Analysis for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Contrast Media and Radiopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 33: Germany Historic Review for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Contrast Media and Radiopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 34: Germany 15-Year Perspective for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Percentage Breakdown of Value Sales for Contrast Media and Radiopharmaceuticals for the Years 2015, 2025 & 2030
- ITALY
- TABLE 35: Italy Recent Past, Current & Future Analysis for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Contrast Media and Radiopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 36: Italy Historic Review for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Contrast Media and Radiopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 37: Italy 15-Year Perspective for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Percentage Breakdown of Value Sales for Contrast Media and Radiopharmaceuticals for the Years 2015, 2025 & 2030
- UNITED KINGDOM
- Diagnostic Radiopharmaceuticals and Contrast Media Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
- TABLE 38: UK Recent Past, Current & Future Analysis for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Contrast Media and Radiopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 39: UK Historic Review for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Contrast Media and Radiopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 40: UK 15-Year Perspective for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Percentage Breakdown of Value Sales for Contrast Media and Radiopharmaceuticals for the Years 2015, 2025 & 2030
- SPAIN
- TABLE 41: Spain Recent Past, Current & Future Analysis for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Contrast Media and Radiopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 42: Spain Historic Review for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Contrast Media and Radiopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 43: Spain 15-Year Perspective for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Percentage Breakdown of Value Sales for Contrast Media and Radiopharmaceuticals for the Years 2015, 2025 & 2030
- RUSSIA
- TABLE 44: Russia Recent Past, Current & Future Analysis for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Contrast Media and Radiopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 45: Russia Historic Review for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Contrast Media and Radiopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 46: Russia 15-Year Perspective for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Percentage Breakdown of Value Sales for Contrast Media and Radiopharmaceuticals for the Years 2015, 2025 & 2030
- REST OF EUROPE
- TABLE 47: Rest of Europe Recent Past, Current & Future Analysis for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Contrast Media and Radiopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 48: Rest of Europe Historic Review for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Contrast Media and Radiopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 49: Rest of Europe 15-Year Perspective for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Percentage Breakdown of Value Sales for Contrast Media and Radiopharmaceuticals for the Years 2015, 2025 & 2030
- ASIA-PACIFIC
- Diagnostic Radiopharmaceuticals and Contrast Media Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
- TABLE 50: Asia-Pacific Recent Past, Current & Future Analysis for Diagnostic Radiopharmaceuticals and Contrast Media by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 51: Asia-Pacific Historic Review for Diagnostic Radiopharmaceuticals and Contrast Media by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 52: Asia-Pacific 15-Year Perspective for Diagnostic Radiopharmaceuticals and Contrast Media by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
- TABLE 53: Asia-Pacific Recent Past, Current & Future Analysis for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Contrast Media and Radiopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 54: Asia-Pacific Historic Review for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Contrast Media and Radiopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 55: Asia-Pacific 15-Year Perspective for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Percentage Breakdown of Value Sales for Contrast Media and Radiopharmaceuticals for the Years 2015, 2025 & 2030
- AUSTRALIA
- Diagnostic Radiopharmaceuticals and Contrast Media Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
- TABLE 56: Australia Recent Past, Current & Future Analysis for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Contrast Media and Radiopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 57: Australia Historic Review for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Contrast Media and Radiopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 58: Australia 15-Year Perspective for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Percentage Breakdown of Value Sales for Contrast Media and Radiopharmaceuticals for the Years 2015, 2025 & 2030
- INDIA
- Diagnostic Radiopharmaceuticals and Contrast Media Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
- TABLE 59: India Recent Past, Current & Future Analysis for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Contrast Media and Radiopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 60: India Historic Review for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Contrast Media and Radiopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 61: India 15-Year Perspective for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Percentage Breakdown of Value Sales for Contrast Media and Radiopharmaceuticals for the Years 2015, 2025 & 2030
- SOUTH KOREA
- TABLE 62: South Korea Recent Past, Current & Future Analysis for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Contrast Media and Radiopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 63: South Korea Historic Review for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Contrast Media and Radiopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 64: South Korea 15-Year Perspective for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Percentage Breakdown of Value Sales for Contrast Media and Radiopharmaceuticals for the Years 2015, 2025 & 2030
- REST OF ASIA-PACIFIC
- TABLE 65: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Contrast Media and Radiopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 66: Rest of Asia-Pacific Historic Review for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Contrast Media and Radiopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 67: Rest of Asia-Pacific 15-Year Perspective for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Percentage Breakdown of Value Sales for Contrast Media and Radiopharmaceuticals for the Years 2015, 2025 & 2030
- LATIN AMERICA
- Diagnostic Radiopharmaceuticals and Contrast Media Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
- TABLE 68: Latin America Recent Past, Current & Future Analysis for Diagnostic Radiopharmaceuticals and Contrast Media by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 69: Latin America Historic Review for Diagnostic Radiopharmaceuticals and Contrast Media by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 70: Latin America 15-Year Perspective for Diagnostic Radiopharmaceuticals and Contrast Media by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
- TABLE 71: Latin America Recent Past, Current & Future Analysis for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Contrast Media and Radiopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 72: Latin America Historic Review for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Contrast Media and Radiopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 73: Latin America 15-Year Perspective for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Percentage Breakdown of Value Sales for Contrast Media and Radiopharmaceuticals for the Years 2015, 2025 & 2030
- ARGENTINA
- TABLE 74: Argentina Recent Past, Current & Future Analysis for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Contrast Media and Radiopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 75: Argentina Historic Review for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Contrast Media and Radiopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 76: Argentina 15-Year Perspective for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Percentage Breakdown of Value Sales for Contrast Media and Radiopharmaceuticals for the Years 2015, 2025 & 2030
- BRAZIL
- TABLE 77: Brazil Recent Past, Current & Future Analysis for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Contrast Media and Radiopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 78: Brazil Historic Review for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Contrast Media and Radiopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 79: Brazil 15-Year Perspective for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Percentage Breakdown of Value Sales for Contrast Media and Radiopharmaceuticals for the Years 2015, 2025 & 2030
- MEXICO
- TABLE 80: Mexico Recent Past, Current & Future Analysis for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Contrast Media and Radiopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 81: Mexico Historic Review for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Contrast Media and Radiopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 82: Mexico 15-Year Perspective for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Percentage Breakdown of Value Sales for Contrast Media and Radiopharmaceuticals for the Years 2015, 2025 & 2030
- REST OF LATIN AMERICA
- TABLE 83: Rest of Latin America Recent Past, Current & Future Analysis for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Contrast Media and Radiopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 84: Rest of Latin America Historic Review for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Contrast Media and Radiopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 85: Rest of Latin America 15-Year Perspective for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Percentage Breakdown of Value Sales for Contrast Media and Radiopharmaceuticals for the Years 2015, 2025 & 2030
- MIDDLE EAST
- Diagnostic Radiopharmaceuticals and Contrast Media Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
- TABLE 86: Middle East Recent Past, Current & Future Analysis for Diagnostic Radiopharmaceuticals and Contrast Media by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 87: Middle East Historic Review for Diagnostic Radiopharmaceuticals and Contrast Media by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 88: Middle East 15-Year Perspective for Diagnostic Radiopharmaceuticals and Contrast Media by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
- TABLE 89: Middle East Recent Past, Current & Future Analysis for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Contrast Media and Radiopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 90: Middle East Historic Review for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Contrast Media and Radiopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 91: Middle East 15-Year Perspective for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Percentage Breakdown of Value Sales for Contrast Media and Radiopharmaceuticals for the Years 2015, 2025 & 2030
- IRAN
- TABLE 92: Iran Recent Past, Current & Future Analysis for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Contrast Media and Radiopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 93: Iran Historic Review for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Contrast Media and Radiopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 94: Iran 15-Year Perspective for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Percentage Breakdown of Value Sales for Contrast Media and Radiopharmaceuticals for the Years 2015, 2025 & 2030
- ISRAEL
- TABLE 95: Israel Recent Past, Current & Future Analysis for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Contrast Media and Radiopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 96: Israel Historic Review for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Contrast Media and Radiopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 97: Israel 15-Year Perspective for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Percentage Breakdown of Value Sales for Contrast Media and Radiopharmaceuticals for the Years 2015, 2025 & 2030
- SAUDI ARABIA
- TABLE 98: Saudi Arabia Recent Past, Current & Future Analysis for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Contrast Media and Radiopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 99: Saudi Arabia Historic Review for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Contrast Media and Radiopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 100: Saudi Arabia 15-Year Perspective for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Percentage Breakdown of Value Sales for Contrast Media and Radiopharmaceuticals for the Years 2015, 2025 & 2030
- UNITED ARAB EMIRATES
- TABLE 101: UAE Recent Past, Current & Future Analysis for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Contrast Media and Radiopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 102: UAE Historic Review for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Contrast Media and Radiopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 103: UAE 15-Year Perspective for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Percentage Breakdown of Value Sales for Contrast Media and Radiopharmaceuticals for the Years 2015, 2025 & 2030
- REST OF MIDDLE EAST
- TABLE 104: Rest of Middle East Recent Past, Current & Future Analysis for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Contrast Media and Radiopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 105: Rest of Middle East Historic Review for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Contrast Media and Radiopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 106: Rest of Middle East 15-Year Perspective for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Percentage Breakdown of Value Sales for Contrast Media and Radiopharmaceuticals for the Years 2015, 2025 & 2030
- AFRICA
- Diagnostic Radiopharmaceuticals and Contrast Media Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
- TABLE 107: Africa Recent Past, Current & Future Analysis for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Contrast Media and Radiopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 108: Africa Historic Review for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Contrast Media and Radiopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 109: Africa 15-Year Perspective for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Percentage Breakdown of Value Sales for Contrast Media and Radiopharmaceuticals for the Years 2015, 2025 & 2030
- IV. COMPETITION
Pricing
Currency Rates